Clinical Trials in Turkey / NCT07689591
Recruiting
Observational
Noninvasive Artificial Venous Stasis for Reperfusion in STEMI
NCT07689591 · tracked via the Priya Life Science Turkey tracker
Condition(s) studied
STEMI - ST Elevation Myocardial Infarction
Study summary
This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.
Eligibility
Inclusion Criteria:
* Having presented within the first 12 hours of symptom onset Being hemodynamically stable (Killip Class I-II)
* STEMI diagnosis confirmed by coronary angiography
* Primary PCI (percutaneous coronary intervention) scheduled
* No pathology in the upper extremity that would prevent cuff application
* Be capable of providing informed consent and provide consent
Exclusion Criteria:
* Presence of cardiogenic shock (systolic blood pressure \< 90 mmHg and Killip Class III-IV)
* Cardiac arrest occurring before or after the procedure
* Need for resuscitation following failed thrombolysis
* History of prior coronary artery bypass surgery
* Concurrent acute aortic dissection
* Venous thromboembolism or pulmonary embolism
* History of an acute infection within the past 7 days
* Chronic kidney disease requiring erythropoietin therapy or currently undergoing hemodialysis
* Presence of liver failure or a hematologic disorder
* Presence of any chronic inflammatory or autoimmune disease
* History of any known malignancy (cancer)
* Current treatment with glibenclamide, corticosteroids, antioxidant vitamins, or cyclosporine at the time of enrollment
* History of chronic (daily) alcohol consumption
* Contraindications to aspirin and/or clopidogrel
* Failure to confirm a STEMI diagnosis via coronary angiography
* Inability to provide informed consent
* Pregnancy
* First 6 months postpartum Conditions in which the administration of thrombolytics is contraindicated
Primary outcome measure(s)
- Presence of Spontaneous Coronary Reperfusion Before Primary PCI — Periprocedural
Spontaneous coronary reperfusion will be defined as the presence of TIMI flow grade 2 or 3 in the infarct-related artery on the first diagnostic coronary angiography performed before guidewire crossing and before primary percutaneous coronary intervention
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Firat University | Elâzığ | Elaziğ | Recruiting |
| Firat University | Elâzığ | Merkez | Recruiting |
More Firat University trials in Turkey
Investigation of Pilates in Office Workers
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07689591 on ClinicalTrials.gov ↗ ← All trials in Turkey